On the tumor level, the role of FLCN in CRC in BHDS is largely unknown [26], few analyses of a somatic second-hit have been performed on tumor tissue from CRC in patients with BHDS, reporting conflicting results[10, 19]. The gene discussed is FLCN; the disease is neoplasm.